TIM-3 Alzheimer’s research is paving the way for a groundbreaking approach to Alzheimer's treatment by leveraging immune system therapy traditionally used in cancer treatment.Researchers have discovered that disabling the TIM-3 checkpoint molecule empowers microglia— the brain's immune cells— to effectively attack and clear away harmful amyloid plaques, significantly enhancing cognitive function in mouse models.